AzTrials
AzTrials

Autism Spectrum DisorderPALSNCT05707923

How Simplified Language Affects Comprehension and Learning in Young Autistic Children

A study testing Linguistic simplification in people with Autism Spectrum Disorder, run by Michigan State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young… Read more about this study

Who is it for?
Ages 1 year to 4 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Linguistic simplification
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
1 siteUnited States
Study dates
1 Jun 2023to 31 May 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 4 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Existing or suspected autism spectrum disorder, confirmed through ADOS-2
  • English as primary language
  • 1-4 years old

Who cannot join

  • Known genetic condition (e.g., Down syndrome, fragile X)
  • Cerebral palsy
  • Acquired brain injury
  • Uncorrected vision or hearing impairment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Courtney Venker, PhD contact

5178842259

cvenker@msu.edu

United States1 site, 1 recruiting
  • Michigan State University

    East Lansing, Michigan, 48824

    Courtney Venker, PhD, 5178842259, cvenker@msu.edu

    Recruiting

Other trials in United States

About this study

Official title: How Single-Word and Telegraphic Simplification Affects Language Processing and Word Learning in Young Children With Autism Spectrum Disorder

The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with ASD (relative to full, grammatical utterances). The proposed project will investigate three specific aims: 1) Determine how single-word and telegraphic simplification affects language processing. 2) Determine how single-word and telegraphic simplification affects word learning. 3) Evaluate child characteristics that may moderate the effects of linguistic simplification on language processing and word learning. Aim 1 will test the hypothesis that children with ASD will process full, grammatical utterances faster and more accurately than single-word or telegraphic utterances. Aim 2 will test the hypothesis that full, grammatical utterances will support word learning better than telegraphic or single-word utterances. Aim 3 will test the hypothesis that language and cognitive skills significantly moderate the effects of linguistic simplification on language processing and word learning in young children with ASD.

Being tested
Linguistic simplification
Keywords
language, autism, intervention, processing, learning, early childhood, treatment, early intervention, telegraphic, language input, looking-while-listening, eye tracking, comprehension, neurodevelopmental disorders
Medical subject headings
Autism Spectrum Disorder, Language, Autistic Disorder, Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Linguistic simplificationBehavioural

    Children will participate in screen-based language processing and word learning tasks in which they hear utterances with different types and amounts of linguistic simplification (i.e., a within-group manipulation).

Study groups in NCT05707923
Study groupRoleWhat they receive
Utterance TypeExperimentalThis study uses a within-participant experimental manipulation. All participants will be exposed to all utterance types (across trials).
Receives: Behavioral: Linguistic simplification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gaze location on Looking-While-Listening (LWL) tasks

    LWL involves a child looking at a screen with two images, one on each side of the screen, while being provided an auditory cue that includes the name of the target image. The primary outcome is a dichotomous variable indicating whether the child is fixated on the target image or the distracter image; gaze directed at neither image will be considered missing. It will be determined whether gaze is to the left or right image, using trained coders who are blind to target side. Gaze location will be observed every 33 ms from 300 ms after onset to 2000 ms after target word onset, for a total of 51 observations per trial. Analyses will focus on differences across trial types and child characteristics in the trajectory of gaze location over the course of the trial.

    Measured: Single assessment per task; total duration less than 10 minutes per task

Secondary outcomes (1)
  1. Gaze location in Teaching Phase of Study 2b (Fast Mapping)

    A secondary outcome measure will be gaze location during the Teaching Phase of the Fast Mapping task (Study 2b). The variable is a dichotomous variable indicating whether the child is fixated on the novel image (only a single image is presented in each trial during the Teaching Phase) or not. It will be determined whether gaze is directed to the novel image, as our prior attempts to manually code single-object trials have not been successful. Only children who successfully calibrate and provide adequate automatic eye-tracking data in the Fast Mapping task will be included. Gaze location will be observed every 33 ms during the Teaching Trials. Analyses will focus on differences across trial types (single-word vs. full, grammatical teaching utterances).

    Measured: Single assessment; total duration less than 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2023
  2. Study start1 Jun 2023
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
104 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05707923
Sponsor's protocol ID
4584124
Other IDs
R01DC020165
Acronym
PALS
Status last verified
Jun 2026
First submitted
3 Jan 2023
Last updated
15 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Dataset will include eye-gaze data, assessment scores, and transcriptions. De-identified analyzed data will be shared with other scientists for non-commercial research purposes in accordance with Michigan State University policy. Pending informed consent, de-identified data will be uploaded to the National Database for Autism Research, and transcripts will be shared with ASDBank. Scientific resources generated will be made available prior to publication if the work is different from our purposes. Following publication, resources will be made available to the broader scientific community on request. Findings and de-identified data will be shared through a variety of avenues, including scientific and clinical conferences, webinars, newsletters and scholarly manuscripts. Identifiable data may be shared if a family provides consent. All peer-reviewed manuscripts will be submitted to NIH's PubMed Central, to be made available at least 12 months after the official publication date.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in